Results 251 to 260 of about 86,846 (266)

Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors

Immunity, 2016
Ivo Gomperts Boneca, Mathias Chamaillard, Takahiro Yamazaki   +2 more
exaly  

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

Annals of Oncology, 2019
Matthew Hellmann, Jungmin Choi, Daniel Zelterman   +2 more
exaly  

Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review

Cancer Treatment Reviews, 2017
Stefanie Rosumeck, Theresa Steeb, Carola Berking   +2 more
exaly  

Immune Checkpoint Blockade

2019
openaire   +1 more source

Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors

International Immunopharmacology, 2018
KRISTIAN Hargadon
exaly  

Immune-related adverse events with immune checkpoint blockade: a comprehensive review

European Journal of Cancer, 2016
Caroline Robert, Michot Jm, Nicolas Noel   +2 more
exaly  

IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer

Cancer Cell, 2023
exaly  

mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma

Molecular Therapy, 2018
Huan Xu, Zheng-Hong Xu, Yuhua Wang
exaly  

AMPK and immune checkpoint blockade

AMPK is a key sensor of energy stress, acting as a master regulator of cell metabolism. This protein is a heterotrimeric serine-threonine kinase which controls the inhibition of anabolic pathways and activation of catabolic pathways to maintain celular energy levels.
Valentines-Casas, Gerard, Universitat Autònoma de Barcelona. Facultat de Biociències   +1 more
openaire   +1 more source

Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system

Trends in Molecular Medicine, 2015
Yago Pico De Coaña, Rolf Kiessling, Aniruddha Choudhury   +2 more
exaly